Angela Clerk

Angela Clerk

Auto-generated profile, based on publicly available information

Angela Clerk

School of Biological Sciences, University of Reading, Whiteknights Campus, Reading, RG6 2AS, UK

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2007 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
ACAngela Clerk
Angela Clerk
TCTimothy E. Cullingford
Timothy E. Cullingford
SFStephen J. Fuller
Stephen J. Fuller
AGAlejandro Giraldo
Alejandro Giraldo
TMThomais Markou
Thomais Markou
PSPeter H. Sugden
Peter H. Sugden

1 October 2020 in Hypertension
Verified
Journal Article
Open access
DMDaniel N. Meijles
Daniel N. Meijles
JCJoshua J. Cull
Joshua J. Cull
TMThomais Markou
Thomais Markou
SCSusanna Cooper
Susanna Cooper
ZHZoe H.R. Haines
Zoe H.R. Haines
ACAngela Clerk
Angela Clerk
Systemic hypertension increases cardiac workload causing cardiomyocyte hypertrophy and increased cardiac fibrosis. An underlying feature is increased production of reactive oxygen species. Redox-sensitive ASK1 (apoptosis signal-regulating kinase 1) activates stress-regulated protein kinases (p38-MAPK [mitogen-activated protein kinases] and JNKs [c-Jun N-terminal kinases]) and promotes fibrosis in various tissues. Here, we determined the specificity of ASK1 signaling in the heart, with the hypothesis that ASK1 inhibitors may be used to manage fibrosis in hypertensive heart disease. Using immunoblotting, we established that moderate levels of H 2 O 2 activate ASK1 in neonatal rat cardiomyocytes and perfused rat hearts. ASK1 was activated during ischemia in adult rat hearts, but not on reperfusion, consistent with activation by moderate (not high) reactive oxygen species levels. In contrast, IL (interleukin)-1β activated an alternative kinase, TAK1 (transforming growth factor–activated kinase 1). ASK1 was not activated by IL1β in cardiomyocytes and activation in perfused hearts was due to increased reactive oxygen species. Selonsertib (ASK1 inhibitor) prevented activation of p38-MAPKs (but not JNKs) by oxidative stresses in cultured cardiomyocytes and perfused hearts. In vivo (C57Bl/6J mice with osmotic minipumps for drug delivery), selonsertib (4 mg/[kg·d]) alone did not affect cardiac function/dimensions (assessed by echocardiography). However, it suppressed hypertension-induced cardiac hypertrophy resulting from angiotensin II (0.8 mg/[kg·d], 7d), with inhibition of Nppa/Nppb mRNA upregulation, reduced cardiomyocyte hypertrophy and, notably, significant reductions in interstitial and perivascular fibrosis. Our data identify a specific reactive oxygen species→ASK1→p38-MAPK pathway in the heart and establish that ASK1 inhibitors protect the heart from hypertension-induced cardiac remodeling. Thus, targeting the ASK1→p38-MAPK nexus has potential therapeutic viability as a treatment for hypertensive heart disease.

1 March 2003 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
ACAngela Clerk
Angela Clerk
SCSharon M Cole
Sharon M Cole
TCTimothy E Cullingford
Timothy E Cullingford
JHJoanne G Harrison
Joanne G Harrison
MJMika Jormakka
Mika Jormakka
DVDonna M Valks
Donna M Valks

1 February 2006 in Cellular Signalling
Verified
Journal Article
Closed access
ACAngela Clerk
Angela Clerk
IAIoanna-Katerina S. Aggeli
Ioanna-Katerina S. Aggeli
KSKonstantina Stathopoulou
Konstantina Stathopoulou
PSPeter H. Sugden
Peter H. Sugden

10 August 2015 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
SFStephen J. Fuller
Stephen J. Fuller
SOSally A. Osborne
Sally A. Osborne
SLSam J. Leonard
Sam J. Leonard
MHMichelle A. Hardyman
Michelle A. Hardyman
GVGeorge Vaniotis
George Vaniotis
ACAngela Clerk
Angela Clerk
Protein kinases are potential therapeutic targets for heart failure, but most studies of cardiac protein kinases derive from other systems, an approach that fails to account for specific kinases expressed in the heart and the contractile cardiomyocytes. We aimed to define the cardiomyocyte kinome (i.e. the protein kinases expressed in cardiomyocytes) and identify kinases with altered expression in human failing hearts. Expression profiling (Affymetrix microarrays) detected >400 protein kinase mRNAs in rat neonatal ventricular myocytes (NVMs) and/or adult ventricular myocytes (AVMs), 32 and 93 of which were significantly up-regulated or down-regulated (greater than two-fold), respectively, in AVMs. Data for AGC family members were validated by qPCR. Proteomics analysis identified >180 cardiomyocyte protein kinases, with high relative expression of mitogen-activated protein kinase cascades and other known cardiomyocyte kinases (e.g. CAMKs, cAMP-dependent protein kinase). Other kinases are poorly investigated (e.g. Slk, Stk24, Oxsr1). Expression of Akt1/2/3, BRaf, ERK1/2, Map2k1, Map3k8, Map4k4, MST1/3, p38-MAPK, PKCδ, Pkn2, Ripk1/2, Tnni3k, and Zak was confirmed by immunoblotting. Relative to total protein, Map3k8 and Tnni3k were up-regulated in AVMs vs. NVMs. Microarray data for human hearts demonstrated variation in kinome expression that may influence responses to kinase inhibitor therapies. Furthermore, some kinases were up-regulated (e.g. NRK, JAK2, STK38L) or down-regulated (e.g. MAP2K1, IRAK1, STK40) in human failing hearts. This characterization of the spectrum of kinases expressed in cardiomyocytes and the heart (cardiomyocyte and cardiac kinomes) identified novel kinases, some of which are differentially expressed in failing human hearts and could serve as potential therapeutic targets.

1 June 2008 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Open access
TCTimothy E. Cullingford
Timothy E. Cullingford
MBMatthew J. Butler
Matthew J. Butler
AMAndrew K. Marshall
Andrew K. Marshall
ETEl Li Tham
El Li Tham
PSPeter H. Sugden
Peter H. Sugden
ACAngela Clerk
Angela Clerk
Krüppel-like transcription factors (Klfs) modulate fundamental cell processes. Cardiac myocytes are terminally-differentiated, but hypertrophy in response to stimuli such as endothelin-1. H2O2 or cytokines promote myocyte apoptosis. Microarray studies of neonatal rat myocytes identified several Klfs as endothelin-1-responsive genes. We used quantitative PCR for further analysis of Klf expression in neonatal rat myocytes. In response to endothelin-1, Klf2 mRNA expression was rapidly increased ( approximately 9-fold; 15-30 min) with later increases in expression of Klf4 and Klf6 ( approximately 5-fold; 30-60 min). All were regulated as immediate early genes (cycloheximide did not inhibit the increases in expression). Klf5 expression was increased at 1-2 h ( approximately 13-fold) as a second phase response (cycloheximide inhibited the increase). These increases were transient and attenuated by U0126. H2O2 increased expression of Klf2, Klf4 and Klf6, but interleukin-1beta or tumor necrosis factor alpha downregulated Klf2 expression with no effect on Klf4 or Klf6. Of the Klfs which repress transcription, endothelin-1 rapidly downregulated expression of Klf3, Klf11 and Klf15. The dynamic regulation of expression of multiple Klf family members in cardiac myocytes suggests that, as a family, they are actively involved in regulating phenotypic responses (hypertrophy and apoptosis) to extracellular stimuli.